Dialysis patients and kidney transplant recipients have considerably greater cancer risk than the general population. This chapter discusses cancer in dialysis patients and kidney transplant recipients, with the exception of…
Urologic complications are inevitable in renal transplantation. Their incidence and effect on graft survival can, however, be minimized. This chapter reviews the types of urologic complications that may occur, maneuvers…
Overview of Incidence and Clinicopathologic Associations Theoretically, the spectrum of liver disease in renal transplant recipients should mimic the spectrum of disease seen in society. It is axiomatic that renal…
Introduction A successful renal transplant is the most effective way of reducing the incidence of cardiovascular disease (CVD) and cardiovascular (CV) mortality in patients with end-stage renal disease (ESRD). Although…
Overview Successful management of infections in kidney transplant recipients is a function of the immune status of the host and the epidemiology of infectious exposures. Transplant recipients are susceptible to…
Acknowledgments I am grateful for the excellent photomicrographs provided by Dr. Rajathurai Murugasa and Professor Ranjit S. Nanra of John Hunter Hospital, Newcastle, NSW, Australia. Introduction Epidemiology Despite the success…
Introduction The enduring techniques of vascular anastomoses described by Alexis Carrel more than a century ago have not changed significantly (see Chapter 1 ). His simple test of satisfactory vascular…
Abbreviations AMR antibody-mediated rejection ATN acute tubular necrosis CAN chronic allograft nephropathy CMV cytomegalovirus CNI calcineurin inhibitor CNIT calcineurin inhibitor toxicity DGF delayed graft function DSA donor-specific antibody EM electron…
Acknowledgments Original work by the authors was funded by the NIH (grant 1U01AI070107) and National Health and Medical Research Council of Australia. Karen Keung is a recipient of the Jacquot…
Naturally occurring antibodies against blood group antigens and acquired alloantibodies against donor human leukocyte antigens (HLAs; secondary to a prior kidney transplant, blood transfusions, or pregnancy) may pose major barriers…
